Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market - Tema Cardiovascular and Metabolic ETF (NASDAQ:HRTS), Altimmune (NASDAQ:ALT)
Weight-loss drugs such as Ozempic and Mounjaro are the leading blockbusters for a new epidemic
Eli Lilly Novo Nordisk World Health Organization Carmot Therapeutics Tale Of Two Investigational Obesity Drugs Altimmune Stock Jumps
Source: benzinga.com